Dr. Nina Sanford study was based on data from the Centers for Disease Control (CDC) and Prevention’s National Health Interview Survey (NHIS), which included more than 13,000 cancer patients from 2014 to 2017. The findings were published in the journal JAMA Oncology last February.
Among people with a cancer diagnosis, vaping increased from 8.5% in 2014 to 10.7% in 2017
The results indicated that among people with a cancer diagnosis, vaping increased from 8.5% in 2014 to 10.7% in 2017. The compiled data also showed that e-cigarette use is especially high among young cancer patients (under the age of 50), with 23% of cancer patients under 50 reporting using e-cigarettes in 2014, in comparison to 27% in 2017.
Sadly, the study author seems to think that this increase in vaping is something to be concerned about. “The gradual but steady increase is quite striking,” said Dr. Sanford an Assistant Professor of Radiation Oncology and doctor who specializes in treating cancers of the gastrointestinal tract. “The high prevalence of e-cigarette use among younger cancer patients and survivors is concerning.”
Research indicating e-cigs’ effectivity as harm reduction and smoking cessation tools
Meanwhile numerous studies have indicated the relative safety of e-cigarettes and their effectiveness as harm reduction and smoking cessation tools. A 2017 study published on BMJ Tobacco Control had specifically suggested that the cancer risk from vaping is significantly lower than that from smoking.
The study titled, “Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke”, carried out by Dr William E Stephens from the University of St Andrews in the UK, had concluded that e-cigarettes have “potencies<1% of tobacco smoke falling within two orders of magnitude of a medicinal nicotine inhaler”.
Read Further: News-Medical